Funds holding “Charles River Laboratories Int”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
13 positions across 13 funds, 2 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| GLO Clough Global Opportunities Fund Multi-Asset | Charles River Laboratories Int | 159864107 | EC | 1.93% | $5.8M | Jul 31, 2026 | full (100 positions) |
| GLQ Clough Global Equity Fund Global Equity | Charles River Laboratories Int | 159864107 | EC | 1.93% | $3.5M | Jul 31, 2026 | full (91 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Charles River Laboratories International Inc | 159864107 | EC | 1.28% | $13.8M | Jun 30, 2026 | full (170 positions) |
| THW abrdn World Healthcare Fund Healthcare | Charles River Laboratories International Inc | 159864107 | EC | 1.00% | $6.9M | Jun 30, 2026 | full (131 positions) |
| HQH abrdn Healthcare Investors Healthcare | Charles River Laboratories International Inc | 159864107 | EC | 0.98% | $13.3M | Jun 30, 2026 | full (154 positions) |
| THQ abrdn Healthcare Opportunities Fund Healthcare | Charles River Laboratories International Inc | 159864107 | EC | 0.96% | $10.1M | Jun 30, 2026 | full (109 positions) |
| TY Tri-Continental Corp U.S. Equity | Charles River Laboratories International Inc | 159864107 | EC | 0.42% | $8.8M | Jun 30, 2026 | full (240 positions) |
| AVK Advent Convertible & Income Fund Convertible Securities | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864AG2 | DBT | 0.35% | $2.7M | Jul 31, 2026 | full (466 positions) |
| BME BlackRock Health Sciences Trust Healthcare | Charles River Laboratories International Inc | 159864107 | EC | 0.20% | $1.1M | Jun 30, 2026 | full (152 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | EC | 0.15% | $340K | Jun 30, 2026 | full (195 positions) |
| GUG Guggenheim Active Allocation Fund U.S. Equity | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | EC | 0.03% | $178K | May 29, 2026 | full (1,258 positions) |
| GGZ Gabelli Global Small & Mid Cap Value Trust Global Equity | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | EC | 0.03% | $45.4K | Jun 30, 2026 | full (321 positions) |
| GOF Guggenheim Strategic Opportunities Fund Multi-Asset | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | EC | 0.00% | $19.5K | May 29, 2026 | full (1,841 positions) |
Matching position names
Charles River Laboratories International Inc · 6CHARLES RIVER LABORATORIES INTERNATIONAL INC · 5Charles River Laboratories Int · 2
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.